TABLE 4.
Distribution of IL-17 level according to stage and DC positivity in CLL
| Variables | CLL | IL-17 | IL-23 | ||||
|---|---|---|---|---|---|---|---|
| % | Median | Min.–Max. | p | Median | Min.–Max. | p | |
| Stage (n=22) | |||||||
| 0 | 31.8 | 13.2 | 11.0–53.7 | 0.070 | 12.7 | 6.0–65.4 | |
| 1 | 40.9 | 91.7 | 11.5–413.6 | 95.7 | 7.9–428.2 | 0.083 | |
| 2 | 18.2 | 18.4 | 11.9–48.3 | 16.1 | 8.4–62.7 | ||
| DC (n=22) | |||||||
| Positive | 18.2 | 21.7 | 12.3–403.4 | 0.774 | 21.0 | 12.7–428.2 | 0.434 |
| Negative | 81.8 | 18.5 | 11.0–413.6 | 14.4 | 6.0–328.8 | ||
Min.: Minimum; Max.: Maximum; CLL: Chronic lymphocytic leukemia; DC: Direct coombs; IL-17: Interleukin -17; IL-23: Interleukin-23.